Nobel Biocare Holding AG (Nobel Biocare Holding AG) Net Income From Continuing Operations : $78.2 Mil (TTM As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Nobel Biocare Holding AG's net income from continuing operations for the six months ended in Dec. 2013 was $78.2 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2013 was $78.2 Mil.

Nobel Biocare Holding AG Net Income From Continuing Operations Historical Data

The historical data trend for Nobel Biocare Holding AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Net Income From Continuing Operations Chart

Nobel Biocare Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Net Income From Continuing Operations

Get a 7-Day Free Trial

200.08

132.80

72.99

80.41

78.17

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Net Income From Continuing Operations	Get a 7-Day Free Trial							200.08	132.80	72.99	80.41	78.17

Nobel Biocare Holding AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2013 was $78.2 Mil.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nobelbiocare.com

Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014